Periodic Review, Requalification & Change Control for Qualified Equipment
Periodic Review Programs for Qualified Equipment Risk Based Frequencies and Scope Periodic Review Programs for Qualified Equipment Risk Based Frequencies and Scope The pharmaceutical industry operates under stringent regulatory expectations that necessitate a robust approach to validating not only processes but also equipment within manufacturing environments. Periodic Reviews of qualified equipment are essential to ensure ongoing compliance and operational excellence….
Template Periodic Review Reports for Equipment and Utility Qualification Status Template Periodic Review Reports for Equipment and Utility Qualification Status In the regulated pharmaceutical industry, maintaining the qualification status of equipment and utilities is crucial to ensure compliance with current Good Manufacturing Practices (cGMP). A structured and thorough periodic review is essential for assessing the performance and continued suitability of…
Change Control Strategies for Qualified Equipment Minimising Revalidation Overkill Change Control Strategies for Qualified Equipment Minimising Revalidation Overkill Introduction to Change Control in Pharmaceutical Validation Change control is a critical aspect of pharmaceutical validation that ensures any modifications to qualified equipment do not adversely affect product quality or patient safety. Regulatory bodies such as the US FDA, EMA, and MHRA…
Audit Ready Evidence for Periodic Review Programs and Lifecycle Management Audit Ready Evidence for Periodic Review Programs and Lifecycle Management Introduction to Evidence for Periodic Review Programs In the pharmaceutical industry, maintaining compliance with Good Manufacturing Practices (cGMP) requirements necessitates a systematic approach to periodic review programs. These programs are crucial in ensuring that equipment and processes remain within validated…
Digital Systems for Tracking Requalification, Periodic Review and Change Control Introduction to Regulatory Expectations in Validation Validation is an essential component of compliant operations within the pharmaceutical industry. Regulatory bodies such as the US FDA, EMA, and MHRA mandate that organizations engage in systematic validation processes to ensure product quality, safety, and efficacy. According to the US FDA Guidance on…
Global Harmonisation of Periodic Review and Requalification SOPs Global Harmonisation of Periodic Review and Requalification SOPs Introduction to Periodic Review and Requalification in Pharmaceutical Validation In the pharmaceutical industry, compliance with regulatory expectations is essential for maintaining the integrity and quality of products. Periodic review and requalification are crucial components of the validation process, ensuring that qualified equipment remains fit…
Risk Based Requalification Protocols When Equipment or Utility Changes Occur Risk Based Requalification Protocols When Equipment or Utility Changes Occur In the pharmaceutical industry, ensuring the quality and safety of products is paramount. One critical aspect of maintaining quality is the validation of equipment and utilities used in manufacturing. Regulatory expectations for validation have evolved, and there is now a…
Regulatory Expectations for Lifecycle Management of Qualified Equipment In the pharmaceutical industry, ensuring the integrity and compliance of qualified equipment is critical to maintaining product quality and patient safety. Regulatory agencies such as the FDA, EMA, MHRA, and guidelines set forth in EU GMP Annex 15 provide a framework for lifecycle management of equipment. This step-by-step tutorial guide aims to…
Integrating Deviation, CAPA and Maintenance Data into Periodic Reviews Integrating Deviation, CAPA and Maintenance Data into Periodic Reviews The pharmaceutical industry operates under stringent regulatory frameworks, necessitating comprehensive validation practices to ensure product quality and patient safety. This article aims to elucidate the integration of deviations, Corrective and Preventive Actions (CAPAs), and maintenance data into the periodic review of qualified…
CMO Oversight for Requalification and Periodic Review of Contract Equipment CMO Oversight for Requalification and Periodic Review of Contract Equipment In the pharmaceutical industry, compliance with regulatory expectations is paramount, especially when it comes to maintaining the quality and efficacy of products. Contract manufacturers (CMOs) play a critical role in this process, where oversight becomes essential to ensure that qualified…